CytoViva introduces breakthrough nano-technology research tool
August 25, 2008--New hyperspectral imaging technology is integrated with the award-winning CytoViva nanoscale microscope.
August 25, 2008--CytoViva Inc. (Auburn, AL), provider of optical imaging solutions to the nano-technology research market, has introduced a new hyperspectral imaging technology (HSI) into its advanced nanoscale microscope system. This combination of technologies enables scientists to make significant advances in a wide range of nano-medicine and nano-materials research initiatives.
Over the past three years, the CytoViva "Nano-scale Microscope System" has been adopted by many of the leading nano-technology research centers. This includes world-class research hospitals such as Johns Hopkins School of Medicine (Baltimore, MD) and M.D. Anderson Cancer Center (Houston), as well as government laboratories within the U.S. Food and Drug Administration (FDA), the National Aeronautics and Space Administration (NASA), and the National Institutes of Health (NIH). This technology has received wide acclaim, including two R&D 100 awards and a Nano50 award.
Hyperspectral imaging is a method of identifying the presence of materials and chemicals based on their unique spectral signature from ultraviolet to infrared wavelengths. By incorporating HSI with the CytoViva nanoscale microscope system, scientists can quantitatively confirm the presence of specific nanoscale materials. The type of HSI incorporated by CytoViva is unique in its ability to capture and report this spectral data within each individual pixel of an image.
A primary application for this technology includes research of nano-particles used as a targeted drug delivery vehicle for treating cancer. With the CytoViva system, scientists can observe these nano-particles as they are absorbed by the cancer cells and quantitatively confirm this process through identification of the particle's unique spectral signature.
According to Chuck Ludwig, CytoViva president, "The development of our hyperspectral imaging capability was driven by customer requirements to quantify images from their CytoViva microscope system. Now these scientists will be able to create spectral signatures of nano-scale materials as they interact with biological or polymeric composites. In addition, HSI can often quantify the presence of materials not easily observed, even with our advanced optical microscope system."
The CytoViva HSI technology has its origins over the past two decades within the Department of Defense. Primarily used in aerial reconnaissance, HSI has been used extensively by the military to identify camouflaged materials.